BioUniversa Overview

  • Founded
  • 2009
  • Status
  • Out of Business
  • Employees
  • 11
  • Latest Deal Type
  • Out of Business

BioUniversa General Information


Developer of diagnostic and therapeutic products intended to achieve novel biomarkers for pancreatic cancer and cardiovascular diseases. The company's products use its BAG3 protein which has useful applications in the diagnosis and treatment of human diseases that have an underlying dysregulation of cell deaths, such as tumor cells, enabling patients with cancer and other cardiovascular diseases to get proper treatment and recover faster.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Diagnostic Equipment
Other Industries
Primary Office
  • Via Antonio Gramsci 85
  • Montoro
  • Italy
+39 089 000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

BioUniversa Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 01-Sep-2019 00.000 Completed Out of Business
2. Early Stage VC 01-Dec-2012 00.000 00.000 Completed Generating Revenue
1. Early Stage VC 29-Dec-2010 $2.64M $2.64M Completed Generating Revenue
To view BioUniversa’s complete valuation and funding history, request access »

BioUniversa Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial